TipRanks
Advertisement
Advertisement

ELVN Stock Latest News

Enliven price target raised to $73 from $62 at Mizuho
The FlyEnliven price target raised to $73 from $62 at Mizuho
1M ago
ELVN
Enliven initiated with an Outperform at William Blair
PremiumThe Fly
Enliven initiated with an Outperform at William Blair
1M ago
ELVN
Enliven initiated with an Overweight at Barclays
PremiumThe Fly
Enliven initiated with an Overweight at Barclays
1M ago
ELVN
Enliven price target raised to $75 from $60 at Baird
PremiumThe Fly
Enliven price target raised to $75 from $60 at Baird
2M ago
ELVN
Enliven price target raised to $82 from $80 at Stifel
PremiumThe Fly
Enliven price target raised to $82 from $80 at Stifel
2M ago
ELVN
Enliven price target lowered to $78 from $80 at Guggenheim
PremiumThe FlyEnliven price target lowered to $78 from $80 at Guggenheim
2M ago
ELVN
Enliven price target raised to $80 from $67 at Goldman Sachs
Premium
The Fly
Enliven price target raised to $80 from $67 at Goldman Sachs
2M ago
ELVN
Enliven price target raised to $68 from $55 at Clear Street
Premium
The Fly
Enliven price target raised to $68 from $55 at Clear Street
2M ago
ELVN
Enliven reports Q2 EPS (49c), consensus (36c)
PremiumThe Fly
Enliven reports Q2 EPS (49c), consensus (36c)
2M ago
ELVN
Enliven price target raised to $67 from $59 at Goldman Sachs
PremiumThe Fly
Enliven price target raised to $67 from $59 at Goldman Sachs
2M ago
ELVN
Enliven price target raised to $65 from $56 at H.C. Wainwright
PremiumThe Fly
Enliven price target raised to $65 from $56 at H.C. Wainwright
3M ago
ELVN
Enliven price target raised to $80 from $60 at Stifel
PremiumThe Fly
Enliven price target raised to $80 from $60 at Stifel
3M ago
ELVN
Enliven price target raised to $70 from $45 at JonesResearch
PremiumThe FlyEnliven price target raised to $70 from $45 at JonesResearch
3M ago
ELVN
Enliven Therapeutics Prices Upsized Public Equity Offering
Premium
Company Announcements
Enliven Therapeutics Prices Upsized Public Equity Offering
3M ago
8K
ELVN
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
Premium
Market News
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
3M ago
ELVN
Enliven rises 9.9%
PremiumThe Fly
Enliven rises 9.9%
3M ago
ELVN
Enliven 8.9M share Spot Secondary priced at $37.50
PremiumThe Fly
Enliven 8.9M share Spot Secondary priced at $37.50
3M ago
ELVN
Enliven announces $250M common stock offering
PremiumThe Fly
Enliven announces $250M common stock offering
3M ago
ELVN
Midday Fly By: Oracle slides, SpaceX on deck for public debut
PremiumThe Fly
Midday Fly By: Oracle slides, SpaceX on deck for public debut
3M ago
GD
MH
Boris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
PremiumRatingsBoris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
3M ago
ELVN
Enliven rises 14.8%
Premium
The Fly
Enliven rises 14.8%
3M ago
ELVN
Enliven advances ELVN-001 with positive Phase 1 data
Premium
Company Announcements
Enliven advances ELVN-001 with positive Phase 1 data
3M ago
8K
ELVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >